Aster DM Healthcare Limited announced changes following its board meeting on 1 July 2026, including appointments and resignations of directors and senior management.
Mr. Varun Khanna was appointed as Managing Director and Group Chief Executive Officer for a term of five years. The board also appointed Mr. Neeraj Jain, Mr. Kewal Handa, and Mr. V K Mathews as independent directors for three years each, and Ms. Ayshwarya Vikram and Mr. Ganesh Mani as non-executive directors.
Resignations were accepted from independent directors Mr. Maniedath Madhavan Nambiar and Mr. C. J. George, and non-executive directors Dr. Zeba Azad Moopen and Mr. Shamsudheen Bin Mohideen Mammu Haji, all effective from 1 July 2026.
The board noted the resignation of Mr. Hitesh Dhaddha as Chief Investor Relations and M&A Officer effective 18 July 2026 and approved a revised list of senior management personnel, including changes in designations for roles such as Chief Executive Officers for India and Bangladesh.
Aster DM Healthcare Limited amended its Employee Stock Option Scheme 2026, renaming it to Aster DM Quality Care Limited Employee Stock Option Scheme 2026 and setting the effective date as the shareholder approval date. Grants will be made to eligible employees of the company and its unlisted subsidiaries, with re-pricing provisions removed.
Ms. Alisha Moopen was redesignated from Deputy Managing Director to Executive Director, and Dr. Azad Moopen and Ms. Alisha Moopen were reclassified as non-key managerial personnel effective 1 July 2026.
Disclaimer: This article is based on company filings submitted to the Bombay Stock Exchange (BSE) and National Stock Exchange of India (NSE) and is for informational purposes only. It does not constitute investment advice or a recommendation. Investors should conduct their own research and consult a qualified financial advisor before making investment decisions.